These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22434076)

  • 1. AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol.
    Habegger KM; Hoffman NJ; Ridenour CM; Brozinick JT; Elmendorf JS
    Endocrinology; 2012 May; 153(5):2130-41. PubMed ID: 22434076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromium enhances insulin responsiveness via AMPK.
    Hoffman NJ; Penque BA; Habegger KM; Sealls W; Tackett L; Elmendorf JS
    J Nutr Biochem; 2014 May; 25(5):565-72. PubMed ID: 24725432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
    Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
    Oki K; Arias EB; Kanzaki M; Cartee GD
    Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation.
    Jørgensen SB; Honeyman J; Oakhill JS; Fazakerley D; Stöckli J; Kemp BE; Steinberg GR
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E57-66. PubMed ID: 19435854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport.
    McCarthy AM; Spisak KO; Brozinick JT; Elmendorf JS
    Am J Physiol Cell Physiol; 2006 Nov; 291(5):C860-8. PubMed ID: 16774991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
    Salt IP; Connell JM; Gould GW
    Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroporated GLUT4-7myc-GFP detects in vivo glucose transporter 4 translocation in skeletal muscle without discernible changes in GFP patterns.
    Knudsen JR; Henriquez-Olguin C; Li Z; Jensen TE
    Exp Physiol; 2019 May; 104(5):704-714. PubMed ID: 30710396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of phosphatidylinositol-3 kinase, AMP-activated kinase and Akt substrate-160 kDa by trans-10, cis-12 conjugated linoleic acid mediates skeletal muscle glucose uptake.
    Mohankumar SK; Taylor CG; Siemens L; Zahradka P
    J Nutr Biochem; 2013 Feb; 24(2):445-56. PubMed ID: 22704782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes.
    Fazakerley DJ; Holman GD; Marley A; James DE; Stöckli J; Coster AC
    J Biol Chem; 2010 Jan; 285(3):1653-60. PubMed ID: 19915010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
    Buhl ES; Jessen N; Schmitz O; Pedersen SB; Pedersen O; Holman GD; Lund S
    Diabetes; 2001 Jan; 50(1):12-7. PubMed ID: 11147776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
    Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
    J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells.
    Li Z; Ni CL; Yao Z; Chen LM; Niu WY
    Metabolism; 2014 Aug; 63(8):1022-30. PubMed ID: 24972503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes.
    Gaidhu MP; Perry RL; Noor F; Ceddia RB
    Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
    Suwa M; Nakano H; Radak Z; Kumagai S
    Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
    Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+).
    Ojuka EO; Jones TE; Nolte LA; Chen M; Wamhoff BR; Sturek M; Holloszy JO
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1008-13. PubMed ID: 11934664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells.
    Bogachus LD; Turcotte LP
    Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1549-61. PubMed ID: 20844250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle.
    Lira VA; Soltow QA; Long JH; Betters JL; Sellman JE; Criswell DS
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1062-8. PubMed ID: 17666490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.